BackNxera Pharma , Ltd. Overview

Nxera Pharma , Ltd. Goodwill

Nxera Pharma , Ltd.'s goodwill is $25B.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$25.09B
↓ 2.74% YoYΔ $-707.77M vs prior year quarter

Peer trimmed avg / median

Loading

Nxera Pharma , Ltd. Goodwill History

Loading

Nxera Pharma , Ltd. vs. peers: Goodwill Comparison

Loading

Nxera Pharma , Ltd. Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nxera Pharma , Ltd. (SOLTF) FAQ

As of the most recent data (June 2026), SOLTF shows a goodwill of $25B. That compares with $26B in the prior-year period — down 2.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SOLTF's goodwill is now $25B (was $26B) — a 2.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Nxera Pharma , Ltd. is outperforming or lagging.

Tracking SOLTF's goodwill over time shows whether Nxera Pharma , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $25B That compares with $26B in the prior-year period — down 2.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Nxera Pharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $25B) with ownership activity and broader fundamentals.

Nxera Pharma , Ltd.'s goodwill is $25B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.